It was found that Sabina's multiple enzymes could improve the symptoms of dyspepsia in patients with functional dyspepsia

Recently, a randomized, double-blind, placebo-controlled trial (http:// published in the Journal of drugs (http:// was also reviewed It was found that digezyme, a multiple complex enzyme of Sabinsa, can improve the dyspepsia symptoms of patients with functional dyspepsia It is understood that digezyme is a non animal patent (http:// mixed enzyme The safety and efficacy of digezyme was evaluated in a randomized, double-blind, placebo-controlled, parallel group trial in which 40 subjects were randomly divided into two groups (1:1 ratio), one group receiving digezyme (50 mg, TID; n = 20) and the other group receiving placebo (n = 20), for 60 days In the experimental group, no matter the symptoms of dyspepsia or irritable bowel syndrome, including upper abdominal pain, discomfort, abdominal distention after meal, heartburn, nausea, hiccups and vomiting after meal, were significantly relieved There was no significant improvement in the control group The study also reported that during the trial, digezyme was safe and well tolerated, with no adverse events, no clinically significant changes in vital signs, and no abnormal laboratory values (Biochemistry and Hematology) Digezyme has been in global supply (http:// for more than ten years The product (http:// is a mixture of five digestive enzymes (amylase, protease, cellulase, lactase and lipase), which help to decompose carbohydrate, complex protein, cellulose fiber, lactose and fat.